{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:14Z","timestamp":1772119994660,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012697","name":"Clifford Craig Foundation","doi-asserted-by":"publisher","award":["G0018836"],"award-info":[{"award-number":["G0018836"]}],"id":[{"id":"10.13039\/100012697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The ectopic overexpression of transient receptor potential vanilloid-1 (TRPV1) has been detected in numerous solid cancers, including breast, prostate, pancreatic, and tongue epithelium cancer. However, the expression of TRPV1 in hematological malignancies remains unknown. Here we show through in silico analysis that elevated TRPV1 mRNA expression occurs in a range of hematological malignancies and presents an optimized flow cytometry method to rapidly assess TRPV1 protein expression for both cell lines and primary patient samples. Three anti-TRPV1 antibodies were evaluated for intracellular TRPV1 detection using flow cytometry resulting in an optimized protocol for the evaluation of TRPV1 in hematological malignant cell lines and patients\u2019 peripheral blood mononuclear cells (PBMC). Overexpression of TRPV1 was observed in THP-1 (acute monocytic leukemia) and U266B1 (multiple myeloma, MM), but not U937 (histiocytic lymphoma) compared to healthy PBMC. TRPV1 was also detected in all 49 patients including B-cell non-Hodgkin\u2019s lymphoma (B-NHL), MM, and others and 20 healthy controls. TRPV1 expression was increased in 8% of patients (MM\u2009=\u20092, B-NHL\u2009=\u20092). In conclusion, we provide an optimized flow cytometry method for routine expression analysis of clinical samples and show that TRPV1 is increased in a subset of patients with hematological malignancies.<\/jats:p>","DOI":"10.1007\/s12032-022-01678-z","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T20:02:32Z","timestamp":1651089752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-5601","authenticated-orcid":false,"given":"Sofia A.","family":"Omari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic P.","family":"Geraghty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhossain A.","family":"Khalafallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Venkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette M.","family":"Shegog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott J.","family":"Ragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"1678_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev.neuro.24.1.487","volume":"24","author":"MJ Caterina","year":"2001","unstructured":"Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci. 2001;24:487\u2013517. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.487.","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"1678_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ygyno.2003.12.040","volume":"93","author":"E Contassot","year":"2004","unstructured":"Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol. 2004;93(1):182\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2003.12.040.","journal-title":"Gynecol Oncol"},{"key":"1678_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/BCTT.S121610","volume":"8","author":"LV Weber","year":"2016","unstructured":"Weber LV, Al-Refae K, W\u00f6lk G, Bonatz G, Altm\u00fcller J, Becker C, Gisselmann G, Hatt H. Expression and functionality of TRPV1 in breast cancer cells. Breast Cancer (Dove Med Press). 2016;8:243\u201352. https:\/\/doi.org\/10.2147\/BCTT.S121610.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1\u20133","key":"1678_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2005.04.010","volume":"515","author":"MG S\u00e1nchez","year":"2005","unstructured":"S\u00e1nchez MG, S\u00e1nchez AM, Collado B, Malagarie-Cazenave S, Olea N, Carmena MJ, Prieto JC, D\u00edaz-Laviada I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol. 2005;515(1\u20133):20\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2005.04.010.","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"1678_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1163\/156856005774423737","volume":"13","author":"A Domotor","year":"2005","unstructured":"Domotor A, Peidl Z, Vincze A, Hunyady B, Szolcsanyi J, Kereskay L, Szekeres G, Mozsik G. Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders. Inflammopharmacology. 2005;13(1\u20133):161\u201377. https:\/\/doi.org\/10.1163\/156856005774423737.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"1678_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cellsig.2011.09.005","volume":"24","author":"S Mergler","year":"2012","unstructured":"Mergler S, Skrzypski M, Sassek M, Pietrzak P, Pucci C, Wiedenmann B, Strowski MZ. Thermo-sensitive transient receptor potential vanilloid channel-1 regulates intracellular calcium and triggers chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells. Cell Signal. 2012;24(1):233\u201346.","journal-title":"Cell Signal"},{"issue":"12","key":"1678_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1080\/15384101.2019.1618119","volume":"18","author":"Z Bao","year":"2019","unstructured":"Bao Z, Dai X, Wang P, Tao Y, Chai D. Capsaicin induces cytotoxicity in human osteosarcoma MG63 cells through TRPV1-dependent and -independent pathways. Cell Cycle. 2019;18(12):1379\u201392. https:\/\/doi.org\/10.1080\/15384101.2019.1618119.","journal-title":"Cell Cycle"},{"key":"1678_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21080966","author":"S Basith","year":"2016","unstructured":"Basith S, Cui M, Hong S, Choi S. Harnessing the therapeutic potential of capsaicin and its analogues in pain and other diseases. Molecules. 2016. https:\/\/doi.org\/10.3390\/molecules21080966.","journal-title":"Molecules"},{"key":"1678_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21070844","author":"V Fattori","year":"2016","unstructured":"Fattori V, Hohmann MS, Rossaneis AC, Pinho-Ribeiro FA, Verri WA. Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules. 2016. https:\/\/doi.org\/10.3390\/molecules21070844.","journal-title":"Molecules"},{"key":"1678_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/bs.apha.2017.01.002","volume":"79","author":"SA Omari","year":"2017","unstructured":"Omari SA, Adams MJ, Geraghty DP. TRPV1 channels in immune cells and hematological malignancies. Adv Pharmacol. 2017;79:173\u201398. https:\/\/doi.org\/10.1016\/bs.apha.2017.01.002.","journal-title":"Adv Pharmacol"},{"issue":"2","key":"1678_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.taap.2005.04.002","volume":"209","author":"JP Wang","year":"2005","unstructured":"Wang JP, Tseng CS, Sun SP, Chen YS, Tsai CR, Hsu MF. Capsaicin stimulates the non-store-operated Ca2+ entry but inhibits the store-operated Ca2+ entry in neutrophils. Toxicol Appl Pharmacol. 2005;209(2):134\u201344. https:\/\/doi.org\/10.1016\/j.taap.2005.04.002.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"1678_CR12","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.4049\/jimmunol.177.7.4322","volume":"177","author":"SR Kim","year":"2006","unstructured":"Kim SR, Kim SU, Oh U, Jin BK. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release. J Immunol. 2006;177(7):4322\u20139.","journal-title":"J Immunol"},{"key":"1678_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1744-8069-4-51","volume":"4","author":"G Spinsanti","year":"2008","unstructured":"Spinsanti G, Zannolli R, Panti C, Ceccarelli I, Marsili L, Bachiocco V, Frati F, Aloisi AM. Quantitative real-time PCR detection of TRPV1-4 gene expression in human leukocytes from healthy and hyposensitive subjects. Mol Pain. 2008;4:51. https:\/\/doi.org\/10.1186\/1744-8069-4-51.","journal-title":"Mol Pain"},{"issue":"6","key":"1678_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.molimm.2006.04.027","volume":"44","author":"CIM Saunders","year":"2007","unstructured":"Saunders CIM, Kunde DA, Crawford A, Geraghty DP. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Mol Immunol. 2007;44(6):1429\u201335.","journal-title":"Mol Immunol"},{"issue":"10","key":"1678_CR15","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.febslet.2009.04.031","volume":"583","author":"BI Toth","year":"2009","unstructured":"Toth BI, Benko S, Szollosi AG, Kovacs L, Rajnavolgyi E, Biro T. Transient receptor potential vanilloid-1 signaling inhibits differentiation and activation of human dendritic cells. FEBS Lett. 2009;583(10):1619\u201324. https:\/\/doi.org\/10.1016\/j.febslet.2009.04.031.","journal-title":"FEBS Lett"},{"issue":"23","key":"1678_CR16","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1016\/j.febslet.2005.08.023","volume":"579","author":"PJ O'Connell","year":"2005","unstructured":"O\u2019Connell PJ, Pingle SC, Ahern GP. Dendritic cells do not transduce inflammatory stimuli via the capsaicin receptor TRPV1. FEBS Lett. 2005;579(23):5135\u20139. https:\/\/doi.org\/10.1016\/j.febslet.2005.08.023.","journal-title":"FEBS Lett"},{"issue":"14","key":"1678_CR17","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1073\/pnas.0407780102","volume":"102","author":"S Basu","year":"2005","unstructured":"Basu S, Srivastava P. Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc Natl Acad Sci U S A. 2005;102(14):5120\u20135. https:\/\/doi.org\/10.1073\/pnas.0407780102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"1678_CR18","doi-asserted-by":"publisher","first-page":"31938","DOI":"10.1074\/jbc.M005722200","volume":"275","author":"M Maccarrone","year":"2000","unstructured":"Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem. 2000;275(41):31938\u201345. https:\/\/doi.org\/10.1074\/jbc.M005722200.","journal-title":"J Biol Chem"},{"issue":"2","key":"1678_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2478\/v10039-012-0044-4","volume":"57","author":"N Himi","year":"2012","unstructured":"Himi N, Hamaguchi A, Hashimoto K, Koga T, Narita K, Miyamoto O. Calcium influx through the TRPV1 channel of endothelial cells (ECs) correlates with a stronger adhesion between monocytes and ECs. Adv Med Sci. 2012;57(2):224\u20139. https:\/\/doi.org\/10.2478\/v10039-012-0044-4.","journal-title":"Adv Med Sci"},{"issue":"2","key":"1678_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/jcp.21857","volume":"221","author":"T Schilling","year":"2009","unstructured":"Schilling T, Eder C. Non-selective cation channel activity is required for lysophosphatidylcholine-induced monocyte migration. J Cell Physiol. 2009;221(2):325\u201334.","journal-title":"J Cell Physiol"},{"issue":"30","key":"1678_CR21","doi-asserted-by":"publisher","first-page":"21244","DOI":"10.18632\/oncotarget.25052","volume":"9","author":"F Punzo","year":"2018","unstructured":"Punzo F, Manzo I, Tortora C, Pota E, Angelo VD, Bellini G, Di Paola A, Verace F, Casale F, Rossi F. Effects of CB2 and TRPV1 receptors\u2019 stimulation in pediatric acute T-lymphoblastic leukemia. Oncotarget. 2018;9(30):21244\u201358.","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"1678_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000445437","volume":"98","author":"SA Omari","year":"2016","unstructured":"Omari SA, Adams MJ, Kunde DA, Geraghty DP. Capsaicin-induced death of human haematological malignant cell lines is independent of TRPV1 activation. Pharmacology. 2016;98(1\u20132):79\u201386. https:\/\/doi.org\/10.1159\/000445437.","journal-title":"Pharmacology"},{"issue":"5","key":"1678_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/carcin\/bgr025","volume":"32","author":"S Caprodossi","year":"2011","unstructured":"Caprodossi S, Amantini C, Nabissi M, Morelli MB, Farfariello V, Santoni M, Gismondi A, Santoni G. Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis. 2011;32(5):686\u201394. https:\/\/doi.org\/10.1093\/carcin\/bgr025.","journal-title":"Carcinogenesis"},{"issue":"10","key":"1678_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.intimp.2010.07.010","volume":"10","author":"J Huang","year":"2010","unstructured":"Huang J, Qiu L, Ding L, Wang S, Wang J, Zhu Q, Song F, Hu J. Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE2 production in a human keratinocyte cell line HaCaT. Int Immunopharmacol. 2010;10(10):1279\u201383. https:\/\/doi.org\/10.1016\/j.intimp.2010.07.010.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"1678_CR25","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/sj.cdd.4401506","volume":"11","author":"C Amantini","year":"2004","unstructured":"Amantini C, Mosca M, Lucciarini R, Perfumi M, Morrone S, Piccoli M, Santoni G. Distinct thymocyte subsets express the vanilloid receptor VR1 that mediates capsaicin-induced apoptotic cell death. Cell Death Differ. 2004;11(12):1342\u201356.","journal-title":"Cell Death Differ"},{"issue":"3","key":"1678_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1471-4159.2007.04582.x","volume":"102","author":"C Amantini","year":"2007","unstructured":"Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, Giangaspero F, Santoni G. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem. 2007;102(3):977\u201390.","journal-title":"J Neurochem"},{"issue":"8","key":"1678_CR27","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/carcin\/bgp138","volume":"30","author":"C Amantini","year":"2009","unstructured":"Amantini C, Ballarini P, Caprodossi S, Nabissi M, Morelli M, Lucciarini R, Cardarelli M, Mammana G, Santoni G. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas\/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis. 2009;30(8):1320.","journal-title":"Carcinogenesis"},{"issue":"4","key":"1678_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00210-008-0391-7","volume":"379","author":"W Everaerts","year":"2009","unstructured":"Everaerts W, Sep\u00falveda MR, Gevaert T, Roskams T, Nilius B, De Ridder D. Where is TRPV1 expressed in the bladder, do we see the real channel? Naunyn Schmiedebergs Arch Pharmacol. 2009;379(4):421\u20135. https:\/\/doi.org\/10.1007\/s00210-008-0391-7.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"11","key":"1678_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood.V112.11.753.753","volume":"112","author":"T Haferlach","year":"2008","unstructured":"Haferlach T, Kohlmann A, Basso G, B\u00e9n\u00e9 M-C, Chiaretti S, Downing JR, Js-Ma H, Hofmann W-K, Kipps TJ, Koay ES. The clinical utility of microarray-based gene expression profiling in the diagnosis and sub-classification of leukemia: final report on 3252 cases from the international mile study group. Blood. 2008;112(11):753.","journal-title":"Blood"},{"issue":"5","key":"1678_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/carcin\/bgr025","volume":"32","author":"S Caprodossi","year":"2011","unstructured":"Caprodossi S, Amantini C, Nabissi M, Morelli MB, Farfariello V, Santoni M, Gismondi A, Santoni G. Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. CARCIN. 2011;32(5):686\u201394. https:\/\/doi.org\/10.1093\/carcin\/bgr025.","journal-title":"CARCIN"},{"issue":"6","key":"1678_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.11.010","volume":"1793","author":"D Gkika","year":"2009","unstructured":"Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim Biophys Acta. 2009;1793(6):953\u20138. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.11.010.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1678_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ygyno.2003.12.040","volume":"93","author":"E Contassot","year":"2004","unstructured":"Contassot E, Tenan M, Schn\u00fcriger V, Pelte MF, Dietrich PY. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol. 2004;93(1):182\u20138.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1678_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1601-0825.2009.01526.x","volume":"15","author":"R Marincs\u00e1k","year":"2009","unstructured":"Marincs\u00e1k R, T\u00f3th BI, Czifra G, M\u00e1rton I, R\u00e9dl P, Tar I, T\u00f3th L, Kov\u00e1cs L, B\u00edr\u00f3 T. Increased expression of TRPV1 in squamous cell carcinoma of the human tongue. Oral Dis. 2009;15(5):328\u201335. https:\/\/doi.org\/10.1111\/j.1601-0825.2009.01526.x.","journal-title":"Oral Dis"},{"issue":"5","key":"1678_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2559.2010.03683.x","volume":"57","author":"C Kalogris","year":"2010","unstructured":"Kalogris C, Caprodossi S, Amantini C, Lambertucci F, Nabissi M, Morelli MB, Farfariello V, Filosa A, Emiliozzi MC, Mammana G, Santoni G. Expression of transient receptor potential vanilloid-1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters. Histopathology. 2010;57(5):744\u201352. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03683.x.","journal-title":"Histopathology"},{"issue":"4","key":"1678_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.eururo.2005.05.018","volume":"48","author":"M Lazzeri","year":"2005","unstructured":"Lazzeri M, Vannucchi MG, Spinelli M, Bizzoco E, Beneforti P, Turini D, Faussone-Pellegrini M-S. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur Urol. 2005;48(4):691\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2005.05.018.","journal-title":"Eur Urol"},{"issue":"1","key":"1678_CR36","first-page":"13","volume":"80","author":"F Ziglioli","year":"2009","unstructured":"Ziglioli F, Frattini A, Maestroni U, Dinale F, Ciufifeda M, Cortellini P. Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism. Acta Biomed. 2009;80(1):13\u201320.","journal-title":"Acta Biomed"},{"key":"1678_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1744-8069-2-22","volume":"2","author":"I Vetter","year":"2006","unstructured":"Vetter I, Wyse BD, Monteith GR, Roberts-Thomson SJ, Cabot PJ. The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway. Mol Pain. 2006;2:22\u201322. https:\/\/doi.org\/10.1186\/1744-8069-2-22.","journal-title":"Mol Pain"},{"issue":"10","key":"1678_CR38","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","volume":"271","author":"DN Cortright","year":"2004","unstructured":"Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1\u2014an update. Eur J Biochem. 2004;271(10):1814\u20139. https:\/\/doi.org\/10.1111\/j.1432-1033.2004.04082.x.","journal-title":"Eur J Biochem"},{"issue":"2","key":"1678_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1476-5381.2012.01851.x","volume":"166","author":"E Fernandes","year":"2012","unstructured":"Fernandes E, Fernandes M, Keeble J. The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol. 2012;166(2):510\u201321.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1678_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1369\/jhc.2008.952820","volume":"57","author":"JR Couchman","year":"2009","unstructured":"Couchman JR. Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem. 2009;57(1):7\u20138. https:\/\/doi.org\/10.1369\/jhc.2008.952820.","journal-title":"J Histochem Cytochem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01678-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01678-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01678-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T07:41:51Z","timestamp":1653982911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01678-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01678-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.04.21261521","asserted-by":"object"}]},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by the Human Research Ethics Committee Network, Tasmania, Australia (H0011050).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was approved by the Human Research Ethics Committee Network, Tasmania, Australia (H0011050).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}],"article-number":"81"}}